Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between the ages of 18 and 75 years old.
- People who had a stroke more than one month ago.
- People who are able to walk, whether or not they need assistance to do so.
- Both men and women are included.
- People who are able to give their consent to take part in the study.
Who may not be able to join:
- People with severe difficulties with thinking, memory, or communication.
- People with significant joint problems or misalignment.
- People with psychological conditions, cognitive difficulties, or other problems affecting the muscles or nervous system.
- People who are pregnant, due to potential risks to the mother and unborn baby.
- People with unstable heart or cardiovascular conditions, such as a heart defect present from birth, blood clots in the veins, coronary heart disease, a previous heart attack, or heart failure.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Muhammad Tarik Arafat, PhD, Department of Biomedical Engineering, Bangladesh University of Engineering and Technology (BUET), Dhaka - 1205.
Phone: 01911764467
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Spatiotemporal Gait Parameter Variability
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.